In a filing, Ionis Pharmaceuticals Inc revealed its EVP Research Swayze Eric unloaded Company’s shares for reported $45278.0 on Nov 12 ’24. In the deal valued at $37.92 per share,1,194 shares were sold. As a result of this transaction, Swayze Eric now holds 33,713 shares worth roughly $1.19 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Monia Brett P sold 6,630 shares, generating $252,294 in total proceeds. Upon selling the shares at $38.05, the Chief Executive Officer now owns 167,393 shares.
Before that, LOSCALZO JOSEPH sold 13,508 shares. Ionis Pharmaceuticals Inc shares valued at $511,426 were divested by the Director at a price of $37.86 per share. As a result of the transaction, LOSCALZO JOSEPH now holds 32,251 shares, worth roughly $1.14 million.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Tuesday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -0.25% to $35.37. Over the last five days, the stock has gained 4.80%. Ionis Pharmaceuticals Inc shares have fallen nearly -30.08% since the year began. Nevertheless, the stocks have fallen -28.83% over the past one year. While a 52-week high of $54.44 was reached on 01/12/24, a 52-week low of $33.33 was recorded on 11/19/24. SMA at 50 days reached $38.48, while 200 days put it at $42.66.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 34.93, which if violated will result in even more drops to 34.49. On the upside, there is a resistance level at 35.91. A further resistance level may holdings at 36.45. The Relative Strength Index (RSI) on the 14-day chart is 41.39, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.71%. Stochastics %K at 24.00% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2024-11-15, growing by 1.18 million shares to a total of 11.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 9.87 million shares. There was a rise of 10.68%, which implies that there is a positive sentiment for the stock.
